With people of minority background and those with obesity and diabetes most at risk for severe cases of COVID-19, the National Institute of Diabetes and Digestive and Kidney Diseases is leading in the research behind why that is. Director Dr. Griffin Rodgers, who contributed to the first effective therapy for sickle cell anemia, updates HealthCast on the institute’s work to lessen the effects of COVID-19 on its research community, as well as other top research and data initiatives at the institution.
HealthCast
Season 2
Episode 17
21m listen
How One NIH Institute is Combating COVID-19 and Health Disparities
Share
NIDDK Director Dr. Griffin Rodgers talks COVID-19, disparities in health, and top priorities at the institute.
-
Dr. Griffin Rodgers Director NIDDK
Related Content
-
New OPM Database is First Step for Federal HR Modernization
OPM launched FWD, replacing FedScope with a more transparent, user-friendly platform featuring interactive workforce data.
8m listen -
Navy Pushes AI from Experiments to Everyday Warfighting Functions
The Navy’s hybrid fleet hinges on a common naval lexicon and trustworthy AI woven into every intelligence function.
6m watch -
Why Federal Experience Matters After Leaving Government
Jose Arrieta, former HHS CIO, discusses how federal civil servants can carry their high-stakes experience and resilience into careers beyond public service.
7m watch -
Officials Build Digital Backbone for Federal Health Care Reform
Federal health agencies are building digital infrastructure to support transparency, interoperability and prescription cost comparisons.
4m read
